XML 180 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share Capital and Public Offerings (Details)
1 Months Ended 12 Months Ended
Dec. 13, 2022
SFr / shares
$ / shares
shares
Dec. 13, 2022
$ / shares
shares
Oct. 07, 2022
shares
Apr. 25, 2022
SFr / shares
$ / shares
shares
Dec. 14, 2021
Oct. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
Share Capital and Public Offerings [line Items]                  
Common shares             35,671,780 32,428,893  
Issuance of common shares       3,015,384          
Purchase of common shares             0    
Pre-funded warrant discount | $ / shares   $ 0.02              
Cash placement (in Dollars) | $             $ 140,000    
Exercise price per share (in Dollars per share) | $ / shares             $ 1.04    
sales agreement description             the Company entered into the Sales Agreement with Virtu, as sales agent. On April 13, 2022, the Company reduced the amount that may be sold pursuant to the Sales Agreement to $230,000. The Company will pay Virtu a commission rate of up to 3.0% of the gross proceeds from each sale of common shares and has agreed to provide Virtu with customary indemnification and contribution rights. The Company will also reimburse Virtu for certain specified expenses in connection with entering into the Sales Agreement. Under the Sales Agreement, common shares will be offered and sold pursuant to the Company’s shelf registration statement on Form F-3 (File No. 333-262489), declared effective by the Securities and Exchange Commission on February 11, 2023. In addition, under the Sales Agreement, sales of common shares may be made by any method permitted by law deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended.The Company has no obligation to sell any of the common shares under the Sales Agreement and may at any time suspend the offering of its common shares upon notice and subject to other conditions    
Common share warrants (in Dollars) | $             $ 3,304,492    
Treasury shares             3,242,887    
Diluted shares percentage         15.00%        
Excess term             10 years    
Price per unit (in Dollars per share) | $ / shares             $ 0.59    
Aggregate intrinsic value for options outstanding and expected to vest (in Dollars) | $             $ 54,899    
Intrinsic value of exercisable options (in Dollars) | $                
Stock-based compensation expense (in Dollars) | $             164,906 $ 22,730
Unrecognized stock-based compensation expense (in Dollars) | $             $ 471,347    
Weighted-average period             1 year 9 months 14 days    
Options vested and exercisable             8 years 9 months 18 days    
Maximum [Member]                  
Share Capital and Public Offerings [line Items]                  
Common per share (in Dollars per share) | $ / shares $ 0.87 $ 0.87              
Exercise price per share (in Dollars per share) | $ / shares       $ 1.04          
Minimum [Member]                  
Share Capital and Public Offerings [line Items]                  
Pre-funded warrant discount | SFr / shares       $ 0.02          
Pre Funded Warrant [Member]                  
Share Capital and Public Offerings [line Items]                  
Purchase price per share (in Dollars per share) | $ / shares       $ 1.04          
Purchase of common shares       1,184,616          
Pre-funded warrant discount | SFr / shares $ 0.02                
Mr. Ronald Hafner [Member]                  
Share Capital and Public Offerings [line Items]                  
Issuance of common shares       95,984          
Convertible Debt [Member]                  
Share Capital and Public Offerings [line Items]                  
Purchase of common shares     1,258,215            
Aggregate principal balance (in Dollars) | $           $ 1,530,000      
Converted into common shares           2,516,429      
BVF Partners L.P. Securities Purchase Agreement [Member]                  
Share Capital and Public Offerings [line Items]                  
Issuance of common shares 5,747,126 5,747,126              
Purchase price per share (in Dollars per share) | $ / shares $ 0.87 $ 0.87              
Purchase of common shares 5,747,127 5,747,127              
Fee amount (in Dollars) | $             $ 700,000    
Aggregate gross proceeds             5.00%    
Unit offering maximum (in Dollars) | $             $ 20,000,000    
Number of common shares             150.00%    
Share capital and public offerings description             Pursuant to the purchase agreement, the Company agreed to grant BVF the right to participate in future offerings of the Company’s securities for a period from the first closing (the “First Closing”) until the earlier of (i) the 30-month anniversary of the initial closing date or (ii) until such time that BVF retains beneficial ownership of less than 9.9% of the issued and outstanding Common Shares. on the same terms, conditions and price provided for in the subsequent financing or the right to purchase a comparable security with a beneficial ownership limitation. In addition, the Company agreed to grant BVF the right to nominate one member to the Company’s Board of Directors and shall continue to recommend to its shareholders to elect such member for a period from the First Closing until such time that BVF retains beneficial ownership of less than 9.9% of the issued and outstanding common shares.    
Private Placement [Member]                  
Share Capital and Public Offerings [line Items]                  
Share capital and public offerings description             the Company closed on a securities purchase agreement for the issuance in a private placement offering of (i) 5,194,802 common shares at a purchase price of $0.77 per share, and (ii) warrants to purchase up to an aggregate of 2,597,401 common shares at an exercise of $0.70 per share. The Company’s Chairman of the Board of Directors, Ronald Hafner, purchased 324,675 common shares in the offering and the Company’s Chief Medical Officer, George Apostol, purchased 1,298,701 common shares in the offering.    
Common Stock [Member]                  
Share Capital and Public Offerings [line Items]                  
Common shares             35,671,780    
Pre Funded Warrant [Member] | BVF Partners L.P. Securities Purchase Agreement [Member]                  
Share Capital and Public Offerings [line Items]                  
Purchase price per unit (in Dollars per share) | $ / shares             $ 1.5    
Exercise price per share (in Dollars per share) | $ / shares             $ 2.03    
Share Capital and Public Offerings [Member] | Convertible Debt [Member]                  
Share Capital and Public Offerings [line Items]                  
Purchase of common shares           1,258,215      
Exercise price per share (in Dollars per share) | $ / shares           $ 0.7      
Private Placement [Member]                  
Share Capital and Public Offerings [line Items]                  
Purchase of common shares             3,150,000